TJX

TJX Companies, Inc. (The)

$161.82

+0.33%
Apr 6, 2026
Bobby Quantitative Model
The TJX Companies, Inc. is the world's largest off-price apparel and home fashions retailer, operating over 5,000 stores across nine countries under banners like T.J. Maxx, Marshalls, and HomeGoods. The company's distinct competitive identity is built on its powerful off-price model, which leverages opportunistic buying of branded merchandise to offer significant discounts, driving high traffic and rapid inventory turnover. The current investor narrative centers on the company's resilience and growth in a challenging consumer environment, with recent financial trends showing strong revenue growth and margin expansion, reinforcing its status as a defensive growth story within the cyclical retail sector.

People also watch

Ross Stores Inc

Ross Stores Inc

ROST

Analysis
BURLINGTON STORES, INC.

BURLINGTON STORES, INC.

BURL

Analysis
The Gap, Inc.

The Gap, Inc.

GAP

Analysis
Urban Outfitters Inc

Urban Outfitters Inc

URBN

Analysis
Boot Barn Holdings, Inc.

Boot Barn Holdings, Inc.

BOOT

Analysis

TJX 12-Month Price Forecast

Historical Price
Current Price $161.82
Average Target $161.82
High Target $186.093
Low Target $137.547

Wall Street consensus

Most Wall Street analysts maintain a constructive view on TJX Companies, Inc. (The)'s 12-month outlook, with a consensus price target around $210.37 and implied upside of +30.0% versus the current price.

Average Target

$210.37

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$129 - $210

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage for TJX is limited in the provided dataset, with only 3 analysts contributing to estimates, which is surprisingly low for a company of its size and market capitalization. The consensus leans bullish, with an average estimated EPS of $6.85 for the period. While a specific consensus price target is not provided in the data, the institutional ratings show a clear pattern of sustained bullish sentiment; recent actions from firms like Barclays, JP Morgan, UBS, and Telsey Advisory Group all maintain 'Overweight' or 'Buy' ratings, with no downgrades visible in the recent history. The target price range implied by the EPS estimates is $6.70 (low) to $7.01 (high), indicating a relatively tight spread of about 4.5%, which suggests a high degree of conviction in the near-term earnings outlook among the covering analysts. The pattern of reiterated bullish ratings, without downgrades, signals strong institutional confidence in TJX's business model and execution, though the low absolute number of analysts in the data may indicate the stock is under-followed relative to its peer group, which can sometimes lead to pricing inefficiencies.

Drowning in data?

Find the real signal!

Bulls vs Bears: TJX Investment Factors

The evidence currently favors the bull case, driven by TJX's exceptional profitability (53.92% ROE), defensive growth profile (8.5% revenue growth, low beta), and robust cash generation. However, the bear case is anchored in a potent valuation risk, with the stock trading at a premium P/E of 30.68x near its historical peak. The single most important tension in the investment debate is whether TJX's superior growth and defensive qualities can justify and sustain its premium valuation in the face of potential economic headwinds or any operational misstep. The resolution of this valuation versus quality dynamic will determine the stock's path forward.

Bullish

  • Exceptional Profitability & ROE: TJX's trailing twelve-month Return on Equity (ROE) of 53.92% is extraordinarily high, indicating superior capital efficiency and a powerful business model. This level of profitability, coupled with a Q4 net margin of 9.99%, demonstrates significant earnings power and operational excellence.
  • Strong Revenue Growth & Defensive Model: Q4 FY2026 revenue grew 8.5% year-over-year to $17.74 billion, showcasing resilience in a challenging consumer environment. The off-price model's defensive nature is confirmed by a beta of 0.727 and a +5.27% relative strength vs. the market over the past month, indicating it is viewed as a haven during market weakness.
  • Robust Cash Flow Generation: The company generated $4.86 billion in TTM Free Cash Flow, providing immense financial flexibility. This strong cash flow funds growth, supports a manageable debt-to-equity ratio of 2.20, and underpins shareholder returns, evidenced by a 33.5% payout ratio.
  • Analyst Conviction & Bullish Sentiment: Institutional analyst sentiment is uniformly bullish, with major firms like Barclays and JP Morgan maintaining 'Overweight' or 'Buy' ratings. The tight 4.5% spread between the low ($6.70) and high ($7.01) EPS estimates suggests high conviction in near-term earnings visibility.

Bearish

  • Premium Valuation at Historical Highs: TJX trades at a trailing P/E of 30.68x and a forward P/E of 28.47x, a significant premium to the retail sector average. This P/E is also near the upper end of its own historical range, pricing in near-perfect execution and leaving little room for error or multiple compression.
  • High Debt Leverage: A debt-to-equity ratio of 2.20 is elevated, indicating significant financial leverage. While supported by strong cash flows, this increases financial risk if interest rates rise further or if the company's earnings power were to decline unexpectedly.
  • Growth Deceleration & High Expectations: While revenue growth is strong at 8.5% YoY, the forward P/E of 28.47x implies the market expects this growth to be sustained. Any sign of deceleration, especially in the core Marmaxx segment (61% of sales), could trigger a sharp valuation re-rating given the premium multiple.
  • Limited Analyst Coverage & Price Near Peak: With only 3 analysts providing estimates, the stock may be under-followed, potentially leading to pricing inefficiencies or exaggerated moves on news. Trading at $161.29, just below the 52-week high, also suggests the stock is technically extended and vulnerable to a pullback.

TJX Technical Analysis

TJX is in a sustained, long-term uptrend, evidenced by a 1-year price change of +29.10%, significantly outperforming the broader market. The stock closed at $161.29, which places it at approximately 99% of its 52-week high of $162.68, indicating it is trading near its all-time highs and reflecting strong bullish momentum and potential overextension. The short-term momentum is positive but shows some deceleration; the stock gained +0.99% over the past month and +4.54% over the past three months, which, while solid, is a slower pace than the explosive 1-year gain, suggesting the uptrend may be entering a consolidation phase. This is supported by a beta of 0.727, indicating the stock is about 27% less volatile than the market (SPY), which has declined -4.28% over the past month, highlighting TJX's defensive characteristics and relative strength of +5.27% over the same period. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $162.68 and support at the 52-week low of $116.37. A decisive breakout above $162.68 would signal a continuation of the powerful bull trend, while a breakdown below the recent consolidation range around $155 could indicate a deeper pullback. The stock's low beta of 0.727 suggests it offers lower systematic risk than the market, which is a key consideration for risk-averse investors seeking stable growth.

Beta

0.73

0.73x market volatility

Max Drawdown

-10.1%

Largest decline past year

52-Week Range

$116-$163

Price range past year

Annual Return

+32.5%

Cumulative gain past year

PeriodTJX ReturnS&P 500
1m+1.6%-2.0%
3m+5.1%-4.8%
6m+15.0%-2.1%
1y+32.5%+30.4%
ytd+4.9%-3.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TJX Fundamental Analysis

TJX exhibits a robust and accelerating revenue trajectory, with Q4 FY2026 revenue of $17.74 billion representing an 8.5% year-over-year growth. This growth is broad-based, led by the Marmaxx segment (T.J. Maxx and Marshalls in the U.S.), which contributed $10.66 billion, or approximately 61% of total sales in the period. The company is highly profitable, with Q4 net income of $1.77 billion and a net margin of 9.99%, demonstrating significant earnings power. Profitability metrics are strong and improving, as evidenced by a trailing twelve-month Return on Equity (ROE) of 53.92% and a gross margin of 30.86% for the quarter, indicating efficient operations and pricing power within its off-price model. The balance sheet and cash flow position is exceptionally healthy. The company generated substantial free cash flow, with TTM Free Cash Flow of $4.86 billion, providing ample internal funding for growth initiatives and shareholder returns. While the debt-to-equity ratio is elevated at 2.20, this is manageable given the strong and consistent cash generation, as reflected in a current ratio of 1.14, which indicates sufficient short-term liquidity.

Quarterly Revenue

$17.7B

2026-01

Revenue YoY Growth

+0.08%

YoY Comparison

Gross Margin

+0.30%

Latest Quarter

Free Cash Flow

$4.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TJX Overvalued?

Given TJX's substantial net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 30.68x and a forward P/E of 28.47x, based on estimated EPS. The modest discount of the forward multiple suggests the market anticipates continued, but perhaps slightly moderated, earnings growth. Compared to sector peers, TJX commands a significant premium. Its trailing P/E of 30.68x is well above typical retail averages, and its Price-to-Sales (P/S) ratio of 2.79x also reflects a premium valuation. This premium is likely justified by the company's superior growth profile, industry-leading profitability (53.92% ROE), and its defensive, counter-cyclical business model which has proven resilient. Historically, TJX's current trailing P/E of 30.68x sits near the upper end of its own historical range observed in the provided data, which has fluctuated between approximately 19x and 35x over recent years. Trading near historical highs suggests the market is pricing in optimistic expectations for sustained earnings growth and margin stability, leaving little room for operational missteps.

PE

30.7x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 19x~40x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

21.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: TJX's primary financial risk stems from its elevated debt-to-equity ratio of 2.20, which, while manageable given $4.86 billion in TTM FCF, increases interest expense sensitivity. Operationally, the company's success is heavily reliant on the continued health of its core Marmaxx segment, which generated 61% of Q4 sales. A slowdown in this segment's 8.5% YoY growth rate would disproportionately impact overall results. Furthermore, maintaining the current net margin of ~10% and gross margin of ~30.9% is critical to justifying its valuation, as margin compression would directly pressure earnings.

Market & Competitive Risks: The most salient market risk is valuation compression. Trading at a trailing P/E of 30.68x, a premium to both peers and its own historical average, TJX is vulnerable to a derating if growth expectations are not met or if investor sentiment shifts away from premium-priced defensive growth stocks. Its low beta of 0.727, while a defensive strength, also means it may not participate fully in strong market rallies. Competitive risks are inherent but mitigated by its unique off-price model; however, increased competition from other off-price retailers or a strategic shift by full-price brands could pressure its opportunistic buying advantage.

Worst-Case Scenario: The worst-case scenario involves a combination of a sharp consumer downturn, leading to a deceleration of revenue growth below 5%, coupled with margin compression from elevated inventory levels or higher buying costs. This would trigger multiple compression as the 'defensive growth' narrative unravels. Analysts would likely cut estimates, and the stock could re-rate towards its historical P/E low near 19x. From the current price of $161.29, a realistic downside in this adverse scenario could be a decline of approximately 28-35% towards the 52-week low of $116.37, representing a significant capital loss for investors.